Even though the effects of SGLT2 inhibitors on blood pressure and weight loss in obese individuals without T2D are identical to those reported in T2D subjects, it is unknown whether such effects can also translate into reduced cardiovascular disease events in this study population
It remains investigational pending completion of phase 3 studies, regulatory review, and publication of full safety and efficacy data
How GLP-1 Therapies May Help GLP-1 receptor agonists were originally developed to improve glycemic control in people with type 2 diabetes
Larger-scale federally licensed compounders (503B outsourcing facilities) have until March 19, 2025, to wind down their production and distribution of compounded tirzepatide
Desmots F, Rissel M, Gilot D et al (2002) Pro-inflammatory cytokines tumor necrosis factor and interleukin-6 and survival factor epidermal growth factor positively regulate the murine GSTA4 enzyme in hepatocytes
This means that, from a pharmacological perspective, taking Bioma alongside Wegovy is generally considered safe for most individuals